a total of 296 evaluable patients with unfavorable categories of malignant lymphoma were randomly assigned treatment with cyclophosphamide , vincristine , and prednisone plus bcnu ( bcop ) or doxorubicin ( chop ) .
C0007257
bcnu
C0053054
bcop